Expression and clinical significance of ARF6 in hepatocellular carcinoma
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the expression and clinical significance of ADP-ribosylation factor 6(ARF6) in hepatocellular carcinoma (HCC). Methods:The expression of ARF6 was determined by tissue microarray and immunohistochemistry in 150 cases of HCC and 48 cases of adjacent cirrhosis tissue. Results:The positive expression of ARF6 in HCC and adjacent cirrhosis tissue were 48.7% (73/150) and 8.3% (4/48) respectively(P < 0.05). The positive expression of ARF6 in HCC was closely related to the portal vein invasion,clinical stage,tumor diameter and AFP level. The results also indicated that a high expression level of ARF6 was associated with worse recurrence-free survival. The median recurrence-free survival was substantially reduced among patients with positive ARF6 protein(36 months vs. 45 months,P = 0.019 1). Conclusion:The expression of ARF6 is closely correlated with the clinical prognosis of HCC. It suggests ARF6 may be a potential prognostic biomarker and therapeutic target for HCC.

    Reference
    Related
    Cited by
Get Citation

吴晓峰,王 科,武正山.组织芯片检测肝细胞肝癌中ARF6蛋白的表达及临床意义[J].南京医科大学学报(自然科学版英文版),2012,(12):1696-1699.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 27,2012
  • Revised:
  • Adopted:
  • Online: January 09,2013
  • Published:
Article QR Code